Holen Sie sich die Stockscreener-App
24.11
6.78%
1.53
Handel nachbörslich:
24.80
0.69
+2.86%
Schlusskurs vom Vortag:
$22.58
Offen:
$22.5
24-Stunden-Volumen:
2.85M
Relative Volume:
1.03
Marktkapitalisierung:
$3.43B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-412.89M
KGV:
-6.2461
EPS:
-3.86
Netto-Cashflow:
$-361.93M
1W Leistung:
-0.25%
1M Leistung:
+84.61%
6M Leistung:
+103.29%
1J Leistung:
-16.11%
1-Tages-Spanne:
$21.77
$24.25
1-Wochen-Bereich:
$21.77
$25.00
52-Wochen-Spanne:
$6.36
$35.68
Dyne Therapeutics Inc Stock (DYN) Company Profile
Firmenname
Dyne Therapeutics Inc
Sektor
Branche
Telefon
(781) 786-8230
Adresse
1560 TRAPELO ROAD, WALTHAM
Vergleichen Sie DYN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DYN
Dyne Therapeutics Inc
|
24.11 | 3.21B | 0 | -412.89M | -361.93M | -3.86 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Dyne Therapeutics Inc Stock (DYN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-08-25 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-06-24 | Eingeleitet | Bernstein | Mkt Perform |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-29 | Eingeleitet | Evercore ISI | Outperform |
| 2025-03-12 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-11-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-10-24 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-21 | Bestätigt | Chardan Capital Markets | Buy |
| 2024-04-30 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-02-27 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-02-15 | Eingeleitet | Oppenheimer | Outperform |
| 2023-01-26 | Eingeleitet | Guggenheim | Buy |
| 2022-07-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2022-07-12 | Eingeleitet | Raymond James | Outperform |
| 2020-10-12 | Eingeleitet | JP Morgan | Overweight |
| 2020-10-12 | Eingeleitet | Jefferies | Buy |
| 2020-10-12 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Dyne Therapeutics Inc Aktie (DYN) Neueste Nachrichten
Will Dyne Therapeutics Inc. stock go up soonJuly 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Assessing Dyne Therapeutics (DYN) Valuation Following Recent Share Price Rally - Yahoo Finance
Dyne Therapeutics Inc. stock volume spike explainedProfit Target & Daily Technical Forecast Reports - newser.com
Analyzing Dyne Therapeutics Inc. with risk reward ratio chartsQuarterly Trade Report & Safe Entry Momentum Tips - newser.com
Is Dyne Therapeutics Inc. stock gaining market shareMarket Growth Summary & Real-Time Sentiment Analysis - newser.com
Dyne Therapeutics to Present at Upcoming Investor Conferences - The Manila Times
Dyne Therapeutics (Nasdaq: DYN) to present at four investor conferences; webcasts available - Stock Titan
Sector ETF performance correlation with Dyne Therapeutics Inc.Sell Signal & Technical Pattern Recognition Alerts - newser.com
What recovery options are there for Dyne Therapeutics Inc.2025 Growth vs Value & Weekly Watchlist for Hot Stocks - newser.com
Can you recover from losses in Dyne Therapeutics Inc.Market Movement Recap & AI Driven Price Forecasts - newser.com
Technical analysis overview for Dyne Therapeutics Inc. stockWeekly Risk Report & Weekly Stock Performance Updates - newser.com
Using RSI to spot recovery in Dyne Therapeutics Inc.2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com
Will Dyne Therapeutics Inc. stock deliver better than expected guidance2025 Institutional Moves & Safe Swing Trade Setup Alerts - newser.com
Why Dyne Therapeutics Inc. stock is seen as undervaluedPortfolio Value Report & Stepwise Swing Trade Plans - newser.com
Is Dyne Therapeutics Inc. stock entering bullish territoryJuly 2025 Market Mood & AI Driven Stock Price Forecasts - newser.com
Historical volatility pattern of Dyne Therapeutics Inc. visualizedJuly 2025 PreEarnings & Intraday High Probability Alerts - newser.com
Can trapped investors hope for a rebound in Dyne Therapeutics Inc.July 2025 Opening Moves & Fast Moving Trade Plans - newser.com
Dyne Therapeutics Inc.’s volatility index tracking explainedRate Hike & Low Drawdown Investment Strategies - newser.com
Is Dyne Therapeutics Inc. reversing from oversold territoryPortfolio Value Summary & Fast Exit and Entry Strategy Plans - newser.com
Dyne Therapeutics, Inc. (DYN) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Qualcomm, Tesla, Intellia Therapeutics, Avidity Biosciences, Dyne Therapeutics: Stocks Making The Biggest Moves Today - MSN
How moving averages guide Dyne Therapeutics Inc. trading2025 Year in Review & Stock Timing and Entry Methods - newser.com
Is Dyne Therapeutics Inc. stock a bargain at current levels2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - newser.com
Dyne Therapeutics Stock Soars After Rival Avidity Biosciences Gets Acquired By Novartis - MSN
Dyne Therapeutics Advances DYNE-101 Study for Myotonic Dystrophy Type 1 - MSN
Finanzdaten der Dyne Therapeutics Inc-Aktie (DYN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):